Navigation Links
APIC 2009 'Targeting Zero' Initiative Offers Practical Tools, Evidence-Based Elimination Strategies to Prevent the Deadliest Healthcare-Associated Infections
Date:1/22/2009

WASHINGTON, Jan. 22 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) has expanded its successful Targeting Zero initiative for 2009 to offer comprehensive education and guidance to prevent the most common and fatal healthcare-associated infections (HAIs).

Targeting Zero features Webinars, conferences and practical tools such as HAI elimination guides. APIC's evidence-based elimination guides translate CDC recommendations into straightforward infection prevention strategies for healthcare workers.

In 2009, APIC will publish a new elimination guide for ventilator-associated pneumonia (VAP), the leading cause of death from HAIs. VAP is a type of pneumonia occurring in people being assisted by mechanical ventilators. In addition to VAP, APIC will also publish elimination guides for catheter-associated urinary tract infections (UTIs), catheter-associated blood stream infections, MRSA in long-term care settings and Acinetobacter baumannii, an antibiotic-resistant bacterium causing infections in wounded military personnel.

"APIC will continue to provide direction and guidance for healthcare workers through clearly outlined implementation strategies for reduction of HAIs," said APIC CEO Kathy Warye. "Our expanded offering has been developed in response to infection preventionists and healthcare leaders who are under increased pressure to improve outcomes and preserve healthcare dollars. As we have since 1973, APIC will help institutions bring the science of HAI reduction to the bedside."

In addition to the new elimination guides, APIC will conduct a 2009 follow-up survey to its ground-breaking MRSA Prevalence Study, first released in 2007. The purpose of the survey will be to gain a better understanding of changes in MRSA prevalence as well as current interventions and their impact.

Also slated for 2009 is a conference focusing on regulatory issues in infection prevention and a series of educational offerings on safe injection practices in ambulatory surgery centers. Additionally, APIC will launch a program to share success stories on performance improvement.

Targeting Zero was initiated in 2008 with educational programs aimed at preventing MRSA, Clostridium difficile infection and the three infections considered preventable by the Centers for Medicare & Medicaid Services (CMS): catheter-associated urinary tract infections (UTIs), catheter-associated blood stream infections, and mediastinitis (a deep infection following coronary artery bypass surgery). A two-day conference for healthcare executives on the new CMS regulations that reduce payment for HAIs was held in September.

As part of the 2008 Targeting Zero initiative APIC conducted a National Prevalence Study of C. difficile in U.S. Healthcare Facilities, the first study to calculate the true magnitude of this infection in the nation's hospitals. The study indicated that 13 out of every 1,000 inpatients were either infected or colonized with C. difficile, a rate 6.5 to 20 times greater than previous incidence estimates. C. difficile is a bacterium that causes diarrhea and more serious intestinal conditions such as colitis.

"New pay-for-performance mandates from CMS and private insurers are driving increased interest in infection prevention," said Warye. "But the most important reason to eliminate HAIs is to save lives and reduce suffering. While not all infections are preventable, working toward zero should be the goal. APIC urges all healthcare institutions to pursue zero HAIs and address the resources, systems and cultural changes that will support this effort."

For more information about APIC Targeting Zero educational programs, please visit: http://www.apic.org/AM/Template.cfm?Section=Targeting_Zero

APIC Targeting Zero 2009

APIC will publish new elimination guides for:

  • VAP (ventilator-associated pneumonia)
  • Catheter-associated urinary tract infections (UTIs)
  • Catheter-associated blood stream infections
  • MRSA in long-term care settings
  • Acinetobacter baumannii

HAIs are a critical public health issue, affecting nearly 2 million Americans annually, with 99,000 deaths and an estimated $20 billion in healthcare costs, according to the CDC.

The CDC estimates the most common HAIs are urinary tract infections (32 percent), surgical site infections (22 percent), pneumonias (15 percent), and blood stream infections (14 percent).

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The association's 12,000 members direct infection prevention programs that save lives and improve the bottom line for hospitals and other healthcare facilities around the globe. APIC advances its mission through education, research, collaboration, practice guidance, public policy and credentialing. Visit APIC online at www.apic.org


'/>"/>
SOURCE Association for Professionals in Infection Control and Epidemiology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Targeting Cancers Own Stem Cells to Fight Recurrence
2. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
3. Health Care Service Corporation Finds Success With Innovative Program Targeting Obesity Epidemic
4. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
5. EGFR-targeting antibody licensed to Abbott
6. Tackling a hard-to-treat childhood cancer by targeting epigenetic changes
7. Tackling Hard-to-treat Childhood Cancer by Targeting Epigenetic Changes
8. NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African-American Voters
9. Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms
10. USHEALTH Group Launches Marketing Program for Two Health Insurance Plans Targeting Latino Residents in Florida
11. L.A. City Attorney Rocky Delgadillo, Patient Activists to Unveil New Television Ad Targeting Health Insurers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... West Dermatology is pleased to announce the newest addition ... 2017, Ms. Vu will join West Dermatology’s large network of medical and cosmetic dermatology ... cancer , and more. She graduated from the University of Florida College of Medicine ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is a set ... the FCPX timeline. This effect isolates horizontal and vertical lines of pixels and sorts ... a rotating or flipping animation and can be changed using a drop-down menu. Create ...
(Date:7/20/2017)... ... July 20, 2017 , ... Coats Rose, P.C. , ... announce their expansion to the Midwest with the establishment of the firm’s new ... Bell, and of counsels, John Peck and Robert Bruns, will establish and anchor ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network of ... Chiropractic , directed by Dr. Russell Horine, DC to their exclusive list of medical ... Dr. Russell Horine serving as the clinic director and his son Dr. Lee Horine ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... July 5, 2017 Pace Analytical, a company of over 2,000 employees ... they have acquired ESC Lab Sciences, further solidifying their position as the top ... . ... President and CEO of Pace Analytical ... Sciences out of Mt Juliet, TN , enhances Pace Analytical,s ...
(Date:6/30/2017)... June 30, 2017 In vitro diagnostics market ... of May, at least ten diagnostic companies have successfully ... public offerings and a loan facility.  The size of ... $80 million.  Kalorama Information provides a monthly IVD ... Diagnostics Knowledge Center. ...
(Date:6/27/2017)... June 27, 2017  Therapix Biosciences Ltd. (Nasdaq: ... specializing in the development of cannabinoid-based drugs, today announced ... Opening Bell in New York, NY ... its initial public offering (IPO) of American Depository Shares ... 2017. Dr. Elran Haber, Ph.D., Chief Executive ...
Breaking Medicine Technology: